| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |